Are you Dr. Ghany?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 49 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10 Center Dr Msc 1800
Bldg 10 Room 9b-16
Bethesda, MD 20892Phone+1 301-402-5115Fax+1 301-402-0491- Is this information wrong?
Summary
- Dr. Marc Ghany, MD is a gastroenterologist in Bethesda, Maryland. He is currently licensed to practice medicine in Louisiana.
Education & Training
- Tulane UniversityFellowship, Gastroenterology, 1992 - 1995
- Yale-New Haven Medical CenterResidency, Internal Medicine, 1989 - 1992
- Royal College of Surgeons IrelandClass of 1989
Certifications & Licensure
- LA State Medical License 1992 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment Start of enrollment: 2000 Jun 01
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B Start of enrollment: 2007 Aug 29
- High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1 Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Ultrasensitive HBsAg Assays-Not Yet Ready for Primetime.Marc G Ghany, Maria Buti, Pietro Lampertico, Hannah M Lee> ;Journal of Hepatology. 2024 Mar 8
- Tools Needed to Support Same-day Diagnosis and Treatment of Current Hepatitis C Infection.Gregory P Fricker, Marc G Ghany, Jorge Mera, Benjamin A Pinsky, John W Ward, Raymond T Chung> ;The Journal of Infectious Diseases. 2023 Sep 22
- 4 citationsControlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.Jordan J Feld, Julie Bruneau, Gregory J Dore, Marc G Ghany, Bettina Hansen, Mark Sulkowski, David L Thomas> ;Clinical Infectious Diseases. 2023 Aug 14
- Join now to see all
Press Mentions
- FDA Keeps Brand-Name Drugs on a Fast Path to Market ― Despite Manufacturing ConcernsJanuary 23rd, 2020
- What’s New in Hepatitis C: Four Themes That Dominated at the Liver MeetingNovember 22nd, 2019
- Hepatitis B Debrief: Key Themes That Emerged at AASLDNovember 19th, 2019
- Join now to see all
Grant Support
- Natural History, Therapy And Pathogenesis Of Chronic Viral Hepatitis CNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Natural History, Therapy And Pathogenesis Of Chronic Viral Hepatitis BNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
- Natural History, Therapy And Pathogenesis Of Chronic Viral Hepatitis CNational Institute Of Diabetes And Digestive And Kidney Diseases2008
- Natural History, Therapy And Pathogenesis Of Chronic Viral Hepatitis BNational Institute Of Diabetes And Digestive And Kidney Diseases2008